275 related articles for article (PubMed ID: 17540579)
1. A mutation in human VAP-B--MSP domain, present in ALS patients, affects the interaction with other cellular proteins.
Mitne-Neto M; Ramos CR; Pimenta DC; Luz JS; Nishimura AL; Gonzales FA; Oliveira CC; Zatz M
Protein Expr Purif; 2007 Sep; 55(1):139-46. PubMed ID: 17540579
[TBL] [Abstract][Full Text] [Related]
2. Human VAPA and the yeast VAP Scs2p with an altered proline distribution can phenocopy amyotrophic lateral sclerosis-associated VAPB(P56S).
Nakamichi S; Yamanaka K; Suzuki M; Watanabe T; Kagiwada S
Biochem Biophys Res Commun; 2011 Jan; 404(2):605-9. PubMed ID: 21144830
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity.
Kim S; Leal SS; Ben Halevy D; Gomes CM; Lev S
J Biol Chem; 2010 Apr; 285(18):13839-49. PubMed ID: 20207736
[TBL] [Abstract][Full Text] [Related]
4. Elimination of the native structure and solubility of the hVAPB MSP domain by the Pro56Ser mutation that causes amyotrophic lateral sclerosis.
Shi J; Lua S; Tong JS; Song J
Biochemistry; 2010 May; 49(18):3887-97. PubMed ID: 20377183
[TBL] [Abstract][Full Text] [Related]
5. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates.
Teuling E; Ahmed S; Haasdijk E; Demmers J; Steinmetz MO; Akhmanova A; Jaarsma D; Hoogenraad CC
J Neurosci; 2007 Sep; 27(36):9801-15. PubMed ID: 17804640
[TBL] [Abstract][Full Text] [Related]
6. Novel splice variants of the amyotrophic lateral sclerosis-associated gene VAPB expressed in human tissues.
Nachreiner T; Esser M; Tenten V; Troost D; Weis J; Krüttgen A
Biochem Biophys Res Commun; 2010 Apr; 394(3):703-8. PubMed ID: 20227395
[TBL] [Abstract][Full Text] [Related]
7. The ALS8-associated mutant VAPB(P56S) is resistant to proteolysis in neurons.
Gkogkas C; Wardrope C; Hannah M; Skehel P
J Neurochem; 2011 Apr; 117(2):286-94. PubMed ID: 21275991
[TBL] [Abstract][Full Text] [Related]
8. Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8).
Kanekura K; Nishimoto I; Aiso S; Matsuoka M
J Biol Chem; 2006 Oct; 281(40):30223-33. PubMed ID: 16891305
[TBL] [Abstract][Full Text] [Related]
9. The VAP protein family: from cellular functions to motor neuron disease.
Lev S; Ben Halevy D; Peretti D; Dahan N
Trends Cell Biol; 2008 Jun; 18(6):282-90. PubMed ID: 18468439
[TBL] [Abstract][Full Text] [Related]
10. Restructured endoplasmic reticulum generated by mutant amyotrophic lateral sclerosis-linked VAPB is cleared by the proteasome.
Papiani G; Ruggiano A; Fossati M; Raimondi A; Bertoni G; Francolini M; Benfante R; Navone F; Borgese N
J Cell Sci; 2012 Aug; 125(Pt 15):3601-11. PubMed ID: 22611258
[TBL] [Abstract][Full Text] [Related]
11. Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons.
Aliaga L; Lai C; Yu J; Chub N; Shim H; Sun L; Xie C; Yang WJ; Lin X; O'Donovan MJ; Cai H
Hum Mol Genet; 2013 Nov; 22(21):4293-305. PubMed ID: 23771029
[TBL] [Abstract][Full Text] [Related]
12. ALS-causing P56S mutation and splicing variation on the hVAPB MSP domain transform its β-sandwich fold into lipid-interacting helical conformations.
Qin H; Wang W; Song J
Biochem Biophys Res Commun; 2013 Feb; 431(3):398-403. PubMed ID: 23333387
[TBL] [Abstract][Full Text] [Related]
13. A mutation in VAPB that causes amyotrophic lateral sclerosis also causes a nuclear envelope defect.
Tran D; Chalhoub A; Schooley A; Zhang W; Ngsee JK
J Cell Sci; 2012 Jun; 125(Pt 12):2831-6. PubMed ID: 22454507
[TBL] [Abstract][Full Text] [Related]
14. Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis.
Kabashi E; El Oussini H; Bercier V; Gros-Louis F; Valdmanis PN; McDearmid J; Mejier IA; Dion PA; Dupre N; Hollinger D; Sinniger J; Dirrig-Grosch S; Camu W; Meininger V; Loeffler JP; René F; Drapeau P; Rouleau GA; Dupuis L
Hum Mol Genet; 2013 Jun; 22(12):2350-60. PubMed ID: 23446633
[TBL] [Abstract][Full Text] [Related]
15. The amyotrophic lateral sclerosis 8 protein, VAP, is required for ER protein quality control.
Moustaqim-Barrette A; Lin YQ; Pradhan S; Neely GG; Bellen HJ; Tsuda H
Hum Mol Genet; 2014 Apr; 23(8):1975-89. PubMed ID: 24271015
[TBL] [Abstract][Full Text] [Related]
16. VAPB interacts with and modulates the activity of ATF6.
Gkogkas C; Middleton S; Kremer AM; Wardrope C; Hannah M; Gillingwater TH; Skehel P
Hum Mol Genet; 2008 Jun; 17(11):1517-26. PubMed ID: 18263603
[TBL] [Abstract][Full Text] [Related]
17. Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria.
Mórotz GM; De Vos KJ; Vagnoni A; Ackerley S; Shaw CE; Miller CC
Hum Mol Genet; 2012 May; 21(9):1979-88. PubMed ID: 22258555
[TBL] [Abstract][Full Text] [Related]
18. The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors.
Tsuda H; Han SM; Yang Y; Tong C; Lin YQ; Mohan K; Haueter C; Zoghbi A; Harati Y; Kwan J; Miller MA; Bellen HJ
Cell; 2008 Jun; 133(6):963-77. PubMed ID: 18555774
[TBL] [Abstract][Full Text] [Related]
19. First evidence of pathogenicity of V234I mutation of hVAPB found in Amyotrophic Lateral Sclerosis.
Chattopadhyay D; Sengupta S
Biochem Biophys Res Commun; 2014 May; 448(1):108-13. PubMed ID: 24792378
[TBL] [Abstract][Full Text] [Related]
20. From ER to Eph receptors: new roles for VAP fragments.
Ackerman SL; Cox GA
Cell; 2008 Jun; 133(6):949-51. PubMed ID: 18555770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
